57 Results for "

cachexia

" in MedChemExpress (MCE) Product Catalog:
Products (57)

57 Results for "cachexia" in MCE Product Catalog:

46
46 Publications Verification
Art. -Nr.: HY-N0109
CAS. Nr.: 10338-51-9
Synonyms: Rhodioloside
Salidroside (Rhodioloside) is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
loading...
    loading...
46
46 Publications Verification
Art. -Nr.: HY-N0109R
CAS. Nr.: 10338-51-9
Synonyms: Rhodioloside (Standard)
Salidroside (Standard) is the analytical standard of Salidroside. This product is intended for research and analytical applications. Salidroside (Rhodioloside) is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
loading...
    loading...
36
36 Cited Publications
Art. -Nr.: HY-112288
CAS. Nr.: 432001-19-9
Reinheit:  99.90%
Synonyms: TTI-101
C188-9 (TTI-101) is a STAT3 inhibitor with a Kd value of 4.7 nM. C188-9 targets the SH2 domain of STAT3, blocks the processes of STAT3 ligand binding, receptor recruitment, homodimerization and phosphorylation, and regulates STAT3-mediated genes associated with tumorigenesis and radioresistance. C188-9 regulates STAT1-mediated genes related to radioresistance and reduces the activation level of STAT1. C188-9 downregulates the expression of DNMT1, enhances DAC-induced demethylation and re-expression of RASSF1A, and simultaneously potentiates the anti-tumor effect of DAC on pancreatic cancer cells. C188-9 inhibits both anchorage-dependent and anchorage-independent growth of cancer cells, induces Apoptosis, blocks the growth of tumor xenografts, and suppresses muscle atrophy. C188-9 maintains muscle mass, increases body weight and improves grip strength in tumor-bearing mice. C188-9 can be used in research related to head and neck squamous cell carcinoma, pancreatic cancer, sepsis-related skeletal muscle wasting, non-small cell lung cancer, acute myeloid leukemia and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-14734
CAS. Nr.: 249921-19-5
Reinheit:  99.94%
Synonyms: RC-1291; ONO-7643
Target:  

GHSR

Forschungsgebiete:  

Endocrinology Cancer

Anamorelin (RC-1291) is an orally active Ghrelin receptor agonist with an EC50 of 0.74 nM. Anamorelin can promote appetite, increase body weight, and stimulate the secretion of growth hormone and insulin-like growth factor-1. Anamorelin can be used in the research of anorexia and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-12176
CAS. Nr.: 173334-57-1
Reinheit:  98.78%
Synonyms: CGP 60536; CGP60536B; SPP 100
Target:  

Renin Autophagy

Forschungsgebiete:  

Cardiovascular Disease Cancer

Aliskiren is an orally active, highly potent and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren can be used for the research of hypertension, cardiovascular diseases and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-12177
CAS. Nr.: 173334-58-2
Reinheit:  99.62%
Synonyms: CGP 60536 hemifumarate; CGP60536B hemifumarate; SPP 100 hemifumarate
Target:  

Renin Autophagy

Forschungsgebiete:  

Cardiovascular Disease Cancer

Aliskiren (CGP 60536; CGP60536B; SPP 100) hemifumarate is an orally active and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren hemifumarate can be used for the research of hypertension, cardiovascular diseases and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-14734A
CAS. Nr.: 861998-00-7
Reinheit:  99.59%
Synonyms: RC-1291 hydrochloride; ONO-7643 hydrochloride
Target:  

GHSR

Forschungsgebiete:  

Endocrinology Cancer

Anamorelin (RC-1291) hydrochloride is an orally active Ghrelin receptor agonist with an EC50 of 0.74 nM. Anamorelin hydrochloride can promote appetite, increase body weight, and stimulate the secretion of growth hormone and insulin-like growth factor-1. Anamorelin hydrochloride can be used in the research of anorexia and cancer cachexia .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-100186
CAS. Nr.: 1539314-06-1
Reinheit:  99.74%
GSK-2881078 is an orally active and nonsteroidal selective androgen receptor modulator (SARM) which act as partial AR agonists in androgenic tissues while mainly as complete AR agonists in synthetic metabolic tissues,induces AR-mediated transcriptional activation in PC3(AR)2 cells (EC50 = 3.99 nM) and the effect can be inhibited by the non-steroidal AR antagonist Bicalutamide. GSK-2881078 can be used in research of muscle weakness and cachexia associated with both chronic and acute illness .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-P99241
CAS. Nr.: 2368950-15-4
Synonyms: PF 06946860

Forschungsgebiete:  

Cancer

Ponsegromab is a Growth differentiation factor 15 (GDF15) inhibitor with human, cynomolgus monkey, and mouse target IC50 values of 0.123 nM, 0.053 nM, and 0.102 nM, respectively . Ponsegromab acts as a chemosensitizer, increases intracellular reactive oxygen species, reduces glutathione levels . Ponsegromab can be used for the research of oxaliplatin-resistant colorectal cancer .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-13676
CAS. Nr.: 595-33-5
Reinheit:  99.69%
Forschungsgebiete:  

Endocrinology Cancer

Megestrol acetate is a synthetic and orally active progesteronal agent. Megestrol acetate is effective as an appetite stimulant for wasting syndromes such as cachexia. Megestrol acetate decreases nuclear and cytosol androgen receptors human BPH tissue. Megestrol acetate has the potential for HIV study and downregulates autophagic catabolic pathway .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-19884B
CAS. Nr.: 2863659-22-5
Synonyms: RM-131 TFA; BIM-28131 TFA
Target:  

GHSR

Forschungsgebiete:  

Metabolic Disease

Relamorelin (RM-131) TFA, a pentapeptide ghrelin analog, is a selective ghrelin/growth hormone secretagogue receptor (GHSR) agonist with a Ki of 0.42 nM for GHS-1a receptor. Relamorelin TFA is centrally penetrant. Relamorelin TFA increases growth hormone levels and accelerates gastric emptying. Relamorelin TFA has the potential for cachexia, gastroparesis, and gastric/intestinal dysmobility disorders research .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-B0580B
CAS. Nr.: 66635-93-6
Synonyms: (+)-Ketorolac
Target:  

Ras

Forschungsgebiete:  

Cancer

(R)-Ketorolac is an orally active Cdc42 and Rac1 inhibitor. (R)-Ketorolac inhibits GTPase. (R)-Ketorolac alters ovarian cancer cell behaviors critical for invasion and metastasis. (R)-Ketorolac ameliorates cancer-associated cachexia .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-13676R
CAS. Nr.: 595-33-5
Megestrol acetate (Standard) is the analytical standard of Megestrol acetate. This product is intended for research and analytical applications. Megestrol acetate is a synthetic and orally active progesteronal agent. Megestrol acetate is effective as an appetite stimulant for wasting syndromes such as cachexia. Megestrol acetate decreases nuclear and cytosol androgen receptors human BPH tissue. Megestrol acetate has the potential for HIV study and downregulates autophagic catabolic pathway .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-148349
CAS. Nr.: 2755890-53-8
Reinheit:  98.44%
Target:  

Melanocortin Receptor

Forschungsgebiete:  

Neurological Disease Metabolic Disease

PF-07258669 is an orally active melanocortin-4 receptor (MC4R) antagonist that antagonizes MC4R with an IC50 of 13 nM (Ki=0.46 nM). PF-07258669 can be used for the research of cachexia, anorexia, or anorexia nervosa .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-129692
CAS. Nr.: 27570-38-3
Reinheit:  93.06%
Target:  

iGluR

Withanone is an active ingredient from the roots of Withania somnifera and a GRP75 inhibitor. Withanone has multifunctional neuroprotective effects in alleviating cognitive dysfunction. In neuron-like cells, Withanone can inhibit NMDA-induced excitotoxicity. Withanone can inhibit white adipose tissue browning by blocking the formation of the GRP75-ANT2-UCP1 complex, thereby alleviating cancer-related cachexia. Withanone can be used in the research of tumors and nervous system diseases .
loading...
    loading...
Art. -Nr.: HY-P5971
CAS. Nr.: 1456699-27-6
Synonyms: Mifomelatide
Target:  

Melanocortin Receptor

Forschungsgebiete:  

Neurological Disease Metabolic Disease

TCMCB07, a cyclic nonapeptide peptide, is an orally active and brain-penetrant melanocortin receptor 4 (MC4R) antagonist. TCMCB07 plays an important role in cachexia. TCMCB07 has potential transport capabilities .
loading...
    loading...
Art. -Nr.: HY-14820A
CAS. Nr.: 945212-59-9
Reinheit:  98.96%
Synonyms: EP-1572 acetate; AEZS-130 acetate
Target:  

GHSR

Forschungsgebiete:  

Neurological Disease Endocrinology Cancer

Macimorelin (EP-1572) acetate, a GH secretagogue, is an orally active GHSR agonist. Macimorelin acetate stimulates GH release. Macimorelin acetate can be used in the research of adult growth hormone deficiency (AGHD), and Cancer anorexia-cachexia syndrome (CACS) .
loading...
    loading...
Art. -Nr.: HY-129531
CAS. Nr.: 445222-91-3
Reinheit:  98.16%
Target:  

E1/E2/E3 Enzyme

Forschungsgebiete:  

Neurological Disease

MuRF1-IN-1 is an orally active MuRF1 inhibitor. MuRF1-IN-1 can inhibit the interaction between MuRF1 and titin as well as E3 ligase activity. MuRF1-IN-1 can alleviate skeletal muscle atrophy and dysfunction in cardiac cachexia .
loading...
    loading...
Art. -Nr.: HY-164027
CAS. Nr.: 2614161-13-4
Target:  

E1/E2/E3 Enzyme

Forschungsgebiete:  

Metabolic Disease Cancer

MyoMed 205 is an orally active muscle ring finger protein 1 (MuRF1) inhibitor. MyoMed-205 reduces ubiquitination and subsequent proteasomal degradation of muscle proteins by inhibiting MuRF1 activity. MyoMed 205 augments muscle performance, attenuates muscle weight loss and alleviates disease-induced weight loss. MyoMed 205 can be used for the research of cancer cachexia, type 2 diabetes mellitus, and heart failure with preserved ejection fraction .
loading...
    loading...
Art. -Nr.: HY-B1834
CAS. Nr.: 3562-63-8
Megestrol is an orally active glucocorticoid and progesterone receptor agonist. Megestrol can alleviate anorexia, cachexia or unexplained significant weight loss associated with acquired immunodeficiency syndrome (AIDS). Megestrol may cause manifestations similar to those of glucocorticoids and increase the risk of mental disorders .
loading...
    loading...